Results 1 to 10 of about 33 (30)

64th Meeting of the French Society of Neuropathology - Meeting Abstracts , December 2nd. 2022 [PDF]

Free Neuropathology, 2023
The French Society of Neuropathology
doaj   +4 more sources

Modifiers of radiation effects on breast cancer incidence revealed by a reanalysis of archival data of rat experiments. [PDF]

J Radiat Res, 2023
Imaoka T, Nishimura M, Daino K, Kakinuma S.   +3 more
europepmc   +1 more source

The pharmacodynamic and mechanistic foundation for the antineoplastic effects of GFH009, a potent and highly selective CDK9 inhibitor for the treatment of hematologic malignancies. [PDF]

Oncotarget, 2023
Zhou F, Tang L, Le S, Ge M, Cicic D, Xie F, Ren J, Lan J, Lu Q.   +8 more
europepmc   +1 more source

E-Posters. [PDF]

Global Spine J, 2021
europepmc   +1 more source

Prenatal exposure to wildfire-related PM_2.5 and autism spectrum disorder in children born in California between 2001-2019. [PDF]

Environ Int
O'Sharkey K, Mitra S, Chow T, Goodrich AJ, Conlon KC, Nuño M, Bennett DH, Raffuse S, Astaneh M, Zhao Y, Kleeman M, Ritz B, Schmidt RJ.   +12 more
europepmc   +1 more source

When I Move, You Move: Physical Activity and Cognitive Functioning Among Older Dyads in Europe. [PDF]

Sage Open Aging
Himmelmann L, Stokes JE, Stuckenschneider T, Zieschang T, Boerner K.   +4 more
europepmc   +1 more source

Post-marketing surveillance of tirabrutinib in 189 patients with r/r primary central nervous system lymphoma. [PDF]

Future Oncol
Kawasaki A, Matsumoto I, Izutsu K, Nishikawa R.   +3 more
europepmc   +1 more source

Inhibitor development and clinical characteristics in children with severe hemophilia A in the ATHN 8 US cohort study. [PDF]

Blood Vessel Thromb Hemost
Thornburg CD, van den Berg HM, Chandler M, Malec L, Manuel M, O'Neill C, Recht M, Taggart E, Carpenter SL, American Thrombosis and Hemostasis Network (ATHN) 8 investigators study group.   +9 more
europepmc   +1 more source

Maximization delays decision-making in acute care nursing. [PDF]

Sci Rep
Tejeiro R, Romero-Moreno A, Paramio A, Cruces-Montes S, Galán-Artímez MC, Santos-Marroquín J.   +5 more
europepmc   +1 more source

A Novel JAK1 Inhibitor SHR0302 Combined With Prednisone for First-Line Treatment of Chronic Graft-Versus-Host Disease: A Phase I Clinical Trial. [PDF]

Cell Transplant
He Q, Sun X, Niu J, Yang J, Wang Y, Huang C, Zhou K, Tong Y, Cai Y, Dong B, Wan L, Song X, Qiu H.   +12 more
europepmc   +1 more source